Market Newsdesk

March 16, 2021 8:33 am

Moody’s Analytics Wins Analytics Innovation Award for CRE Solution

NEW YORK–(BUSINESS WIRE)–
Moody’s Analytics has won the Analytics Innovation category in the 2021 FinTech Breakthrough Awards. We earned this award for innovation in our commercial real estate (CRE) offering.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005589/en/

Specifically recognized was our Custom Markets model, which gives customers the ability to create unique, customized submarkets of commercial and multifamily properties.

“Winning a FinTech Breakthrough award for our innovation in the CRE space is really exciting,” said Keith Berry, General Manager at Moody’s Analytics. “Our customers need different and more advanced options for their CRE analysis—especially as the economy continues recovering—and the Custom Markets model is a great example. The custom analysis it produces builds on customers’ own expertise and helps them make better CRE investment decisions.”

The Custom Markets model lets users of the Moody’s Analytics REIS platform apply their local market expertise on top of a rich historical dataset. Multiple submodels leverage our vast economic and CRE performance data in property-level forecasts based on the stage of each property (stabilized or under construction) as well its evolution over time.

Included as well are 2-year future rent and vacancy rate projections based on each property and/or development project within the specified area. In addition, custom market performance indicators are benchmarked to Moody’s Analytics REIS-defined markets and submarkets, helping users identify pockets of over- and under-performance.

The Custom Markets tool is one of many recent enhancements to the Moody’s Analytics REIS platform, the cornerstone of Moody’s Analytics CRE Solutions and a valuable decision-making tool for commercial real estate investors, lenders, analysts, and regulators.

Learn more about this award, which adds to the recognition for Moody’s Analytics.

About Moody’s Analytics

Moody’s Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moody’s Analytics, visit our website or connect with us on Twitter and LinkedIn.

Moody’s Analytics, Inc. is a subsidiary of Moody’s Corporation (NYSE: MCO). Moody’s Corporation reported revenue of $5.4 billion in 2020, employs approximately 11,400 people worldwide and maintains a presence in more than 40 countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005589/en/

JUSTIN BURSZTEIN

Moody’s Analytics Communications

+1.212.553.1163

Moody’s Analytics Media Relations

moodysanalytics.com

twitter.com/moodysanalytics

linkedin.com/company/moodysanalytics

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo

March 16, 2021 8:33 am

Green Hygienics Holdings Inc. Closes on Acquisition of Castillo Seed Co. Assets

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Green Hygienics Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) announces today that it has closed the acquisition of certain assets of Castillo Seed LLC. (Castillo), a pioneering hemp seed company with an extensive library of proven genetics backed by years of R&D efforts.

The assets include seed inventories, thousands of stock plants, an established genetics portfolio, and greenhouse and seed production equipment. All acquired assets will be moved to the Company-owned property, Sol Valley Ranch, forming the basis for the Company’s hemp genetics division. Sol Valley Ranch will have in-house compliance and full analytic testing capabilities after completing its field-side laboratory and will immediately begin developing some of the industry’s first USDA Certified Organic hemp seeds.

“We saw an opportunity to fast-track our genetics program by procuring a developed genetics portfolio which will not only save 3-5 years of R&D work but also allow the Company to propagate proprietary USDA Certified Organic seeds as soon as July of this year. USDA stamped seeds are a rare find and it just reaffirms our goal to becoming one of the most highly certified Hemp companies on the planet,” stated Kyle MacKinnon, COO. “Last year in 2020, we showed our ability to cultivate premium hemp and last week the Company acquired Primordia, which included 10,000 acres of legacy farming relationships and a multitude of other beneficial assets, including bulk wholesale finished product inventory. We are now entering a phase of rapid growth through acquisitions and continue to grow our own secure supply chain.”

About Castillo Seed Co.

Castillo operated over 1 million square feet of greenhouses under organic conditions and developed a deep portfolio of genetics for the purpose of selling seeds, seedlings and clones to various customers around the globe.

About Green Hygienics Holdings

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company owns the largest single USDA Certified Organic hemp for CBD farm in North America with 824 acres and approx. 400,000 square feet of greenhouse.
The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.
The Company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, Green Hygienics intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.
We are building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives. Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.
For further information about Green Hygienics Holdings Inc., please visit the Company’s website at: www.greenhygienics.com

View our corporate video: here.

Corporate Communications:

Heidi Thomasen
Thomasen Communications
[email protected]
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

March 16, 2021 8:33 am

SAIC Appoints New Board Member and Board Fellow

SAIC Appoints New Board Member and Board Fellow

SAIC board member Dr. Garth Graham brings expertise in public and community health; SAIC board fellow Mike McGrew joins as observer through Heidrick & Struggles’ Director Institute

RESTON, Va.–(BUSINESS WIRE)–
Science Applications International Corp. (NYSE: SAIC) announced today the appointment of Dr. Garth Graham, director and global head of Healthcare and Public Health Partnerships at YouTube and a former U.S. Deputy Assistant Secretary of Health at the Department of Health and Human Services, to the company’s board of directors, effective March 15.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005533/en/

SAIC appointed Dr. Garth Graham, director and global head of Healthcare and Public Health Partnerships at YouTube and a former U.S. Deputy Assistant Secretary of Health at the Department of Health and Human Services, to the company’s board of directors. (Photo: Business Wire)

“We are excited to welcome Dr. Graham to SAIC’s board of directors. He is a leading authority on social determinants of health and health equity. His broad experience in health care, technology, and groundbreaking programs in public and community health settings brings a unique perspective that will further guide SAIC as a leader in digital transformation and service to our citizens,” said Donna Morea, SAIC board chair. “His passion and energy will be critical toward helping SAIC transform government through innovation, technology, and diverse talent.”

Graham will serve on the Human Resources and Compensation Committee bringing the board’s total membership to 10. With the appointment of Graham, SAIC’s board is comprised of 60% women and people of color.

“SAIC’s board is committed to aligning with SAIC’s inclusion, diversity, and equity values,” said Morea. “A more inclusive and diverse board enables us to offer richer, relevant experiences and authentic perspectives to drive exceptional business results.”

SAIC’s board of directors will also welcome new board fellow, Mike McGrew, executive vice president, chief communications and corporate social responsibility and diversity officer for Constellation Brands, a leading Fortune 500 company and international producer and marketer of beer, wine, and spirits based in Victor, New York. McGrew joins SAIC’s board through the Heidrick and Struggles’ Director Institute, a comprehensive development program, founded with advisors EY, Skadden Arps, and The Rock Center for Corporate Governance at Stanford University, that prepares diverse executives for broader operating roles and corporate governance.

These CEO-selected leaders are mentored and encouraged to provide insights and experiences, enhance boardroom discussions and create potential succession opportunities. In reciprocity, SAIC’s Chief Human Resources Officer Michelle O’Hara will observe Constellation’s board as a participant in the Directors Institute program.

About Dr. Garth Graham

Dr. Garth Graham is currently a director and global head of Healthcare for YouTube where he leads the effort of creating easily understandable and accessible health care content for the online video provider owned by Alphabet, Inc. Prior to joining YouTube in Jan. 2021, Graham was vice president of Community Health and Impact for CVS Health where he oversaw community health initiatives, drove the company’s efforts to address social determinants of health through innovative partnerships and evidence-based grant programs with leading organizations. Most notably, during the COVID-19 pandemic, Graham led CVS’s pandemic community testing strategy including national community sites.

Graham joined CVS Health through the Aetna acquisition where he was the vice president of Community Health and president of the Aetna Foundation. A cardiologist by training and a professor of medicine at the University of Florida, Graham was also the former U.S. Deputy Assistant Secretary of Health at the U.S. Department of Health and Human Services where he also ran the Office of Minority Health.

Graham holds a medical degree from Yale University School of Medicine, a master’s degree of Public Health from Yale, and a bachelor’s degree in Biology from Florida International University. He completed clinical training at Massachusetts General Hospital and Johns Hopkins where he trained in cardiology and interventional cardiology. He holds three board certifications, including internal medicine, cardiology, and interventional cardiology.

About Mike McGrew

Mike McGrew is Constellation Brand’s executive vice president, chief communications and corporate social responsibility officer reporting to Bill Newlands, president & chief executive officer. In this role, he is responsible for overseeing all aspects of the company’s communications efforts, including internal and external global communications, brand public relations, corporate branding and reputation, investor relations, and CSR.

Based in Chicago, McGrew joined Constellation Brands in 2014 as senior director, communications for the beer division. He has held a number of progressive leadership roles within the company, including serving as a member of the Operational Executive Management Committee, providing valuable stakeholder and business perspective, and leading the development and execution of impactful communication campaigns to support various strategic priorities and investments that have contributed to the company’s overall success.

Prior to joining Constellation Brands, McGrew held a number of roles in corporate communications at Grainger, Alliant Foodservice and Morton International. He is a Leadership Greater Chicago Fellow, and serves on the Board of Directors for Urban Initiatives.

McGrew earned his master’s degree in Integrated Marketing Communications and his bachelor’s degree in Organizational Studies from Northwestern University.

About SAIC

SAIC^® is a premier Fortune 500^® technology integrator driving our nation’s digital transformation. Our robust portfolio of offerings across the defense, space, civilian, and intelligence markets includes secure high-end solutions in engineering, IT modernization, and mission solutions. Using our expertise and understanding of existing and emerging technologies, we integrate the best components from our own portfolio and our partner ecosystem to deliver innovative, effective, and efficient solutions that are critical to achieving our customers’ missions.

We are 25,500 strong; driven by mission, united by purpose, and inspired by opportunities. Headquartered in Reston, Virginia, SAIC has pro forma annual revenues of approximately $7.1 billion. For more information, visit saic.com. For ongoing news, please visit our newsroom.

Forward-Looking Statements

Certain statements in this release contain or are based on “forward-looking” information within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by words such as “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “guidance,” and similar words or phrases. Forward-looking statements in this release may include, among others, estimates of future revenues, operating income, earnings, earnings per share, charges, total contract value, backlog, outstanding shares and cash flows, as well as statements about future dividends, share repurchases and other capital deployment plans. Such statements are not guarantees of future performance and involve risk, uncertainties and assumptions, and actual results may differ materially from the guidance and other forward-looking statements made in this release as a result of various factors. Risks, uncertainties and assumptions that could cause or contribute to these material differences include those discussed in the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Legal Proceedings” sections of our Annual Report on Form 10-K, as updated in any subsequent Quarterly Reports on Form 10-Q and other filings with the SEC, which may be viewed or obtained through the Investor Relations section of our website at saic.com or on the SEC’s website at sec.gov. Due to such risks, uncertainties and assumptions you are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof. SAIC expressly disclaims any duty to update any forward-looking statement provided in this release to reflect subsequent events, actual results or changes in SAIC’s expectations. SAIC also disclaims any duty to comment upon or correct information that may be contained in reports published by investment analysts or others.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005533/en/

Lauren Presti

703.676.8982

[email protected]

KEYWORDS: Virginia United States North America

INDUSTRY KEYWORDS: Data Management Technology Manufacturing Other Technology Software Networks Defense Contracts Internet Engineering Hardware

MEDIA:

Logo

Photo

Mike McGrew, executive vice president, chief communications and corporate social responsibility and diversity officer for Constellation Brands, joins SAIC as a board fellow. (Photo: Business Wire)

Photo

March 16, 2021 8:33 am

OSI Systems Receives $6 Million Award for Patient Monitoring Solutions

OSI Systems Receives $6 Million Award for Patient Monitoring Solutions

HAWTHORNE, Calif.–(BUSINESS WIRE)–
OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS) today announced that its Healthcare division, Spacelabs Healthcare^®, received orders valued at approximately $6 million from a U.S. hospital to provide patient monitoring solutions and related accessories. These products are expected to be installed in several critical care areas, including operating rooms and intensive care units for post anesthesia, neonatal, and pediatrics.

“We are pleased to work with this customer and look forward to delivering our advanced patient monitoring solutions to help provide comprehensive care,” commented Deepak Chopra, OSI Systems’ Chairman and CEO.

About OSI Systems

OSI Systems is a vertically integrated designer and manufacturer of specialized electronic systems and components for critical applications in the homeland security, healthcare, defense and aerospace industries. The Company combines more than 40 years of electronics engineering and manufacturing experience with offices and production facilities in more than a dozen countries to implement a strategy of expansion into selective end product markets. For more information on OSI Systems or any of its subsidiary companies, visit www.osi-systems.com. News Filter: OSIS-G

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements relate to OSI Systems’ current expectations, beliefs, and projections concerning matters that are not historical facts. Forward-looking statements are not guarantees of future performance and involve uncertainties, risks, assumptions, and contingencies, many of which are outside OSI Systems’ control and which may cause actual results to differ materially from those described in or implied by any forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are based on currently available information and speak only as of the date on which they are made. OSI Systems assumes no obligation to update any forward-looking statement made in this press release that becomes untrue because of subsequent events, new information, or otherwise, except to the extent it is required to do so in connection with its ongoing requirements under Federal securities laws. For a further discussion of factors that could cause OSI Systems’ future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in OSI Systems’ most recently filed Annual Report on Form 10-K and other risks described therein and in documents subsequently filed by OSI Systems from time to time with the Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005382/en/

OSI Systems, Inc.

Ajay Vashishat

Vice President, Business Development

310-349-2237

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Health Medical Devices Technology Hospitals Software General Health Hardware

MEDIA:

March 16, 2021 8:33 am

EXL Health Analysis Charts Long-Term Impact of COVID-19 on Health Plans and Providers

Per Member, Per Month Insurance Costs more than double for five months following COVID-19 Diagnosis; Delayed Care Forecast to drive 18% increase in future Avoidable Healthcare Spend

NEW YORK, March 16, 2021 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading Operations Management and Analytics company, today announced the publication from its EXL Health division of new analysis that tracks healthcare spending and utilization over the past year to chart the potential long-term impacts of COVID-19 on health plans and providers. The paper, Delivering the Vaccine is Just the Beginning – How to Confront the Long-Term Impact of COVID, finds that average per member, per month health insurance costs more than double following a COVID-19 diagnosis, and delayed care is associated with a projected 18% increase in future avoidable healthcare spending.

“The healthcare industry is facing a strong set of headwinds as we start the slow climb out of the COVID-19 pandemic,” said Sam Meckey, Executive Vice President and Business Head, EXL Health. “While we are starting to see positive progress with the vaccine roll-out, there are several financial, structural, behavioral and socioeconomic issues that need to be addressed before we can close the significant gaps in care that emerged over the past year. By conducting this analysis, we hope to help triage the recovery by spotlighting the areas in need of most urgent attention.”

Drawing on several EXL Health data and analytics assets, the research piece evaluated the impact of COVID-19 on health insurance costs, gaps in preventive and routine care and social determinants of health. Following were the key findings:

Monthly Health Insurance Costs Surge and Stay Elevated Following COVID-19 Diagnosis: The average per member per month insurance cost for a sample representative commercial population with no preexisting conditions is $179. That number jumps to and stays elevated, at an average of $470 per month for the next five months post COVID diagnosis month.
Preexisting Conditions Create a Multiplier Effect for COVID-19-Related Costs: For members with just one preexisting condition, the average per member per month insurance cost starts at $369 and stays elevated, at an average of $624 for the next five months post COVID diagnosis month. For people with two or more preexisting conditions, the average per member per month insurance cost is $1,541 for the five months following a COVID-19 diagnosis.
Gaps in Routine Care/Screening Set Stage for Increased Chronic Conditions: Preventive screening and routine care declined sharply during 2020 across a wide range of diagnosis codes. Pre-hypertension screening, for example, fell 7.23% and lipid panel testing fell 6.85% in January through October of 2020.
Projected 18% Increase in Future Avoidable Spend: The combined effect of delayed care, increase in gaps and social barriers can potentially lead to increases in future avoidable spend for populations. In our sample commercial population, we project the potential for this avoidable future spend across ED visits, inpatient visits and readmissions to increase by roughly 18%.

In addition to the analysis of COVID-19 headwinds, the paper also outlines a playbook for the healthcare industry to navigate these challenges, including the development of patient education and assistance tools, the use of AI to flag at-risk patients for vaccine prioritization, handle social disparities and ongoing patient tracking and care management. The full paper can be accessed here.

For more information on EXL Health, click here.

About EXL

EXL (NASDAQ: EXLS) is a leading operations management and analytics company that helps our clients build and grow sustainable businesses. By orchestrating our domain expertise, data, analytics and digital technology, we look deeper to design and manage agile, customer-centric operating models to improve global operations, drive profitability, enhance customer satisfaction, increase data-driven insights, and manage risk and compliance. Headquartered in New York, EXL has approximately 31,900 professionals in locations throughout the United States, the United Kingdom, Europe, India, the Philippines, Colombia, Canada, Australia and South Africa. EXL serves customers in multiple industries including insurance, healthcare, banking and financial services, utilities, travel, transportation and logistics, media and retail, among others. For more information, visit www.exlservice.com.

Investor Relations
Steven N. Barlow
Vice President Investor Relations
212-624-5913
[email protected]

Media - US
Michael Sherrill
Vice President Marketing
646-419-0778
[email protected]

Media - Europe, India and APAC
Shailendra Singh
Vice President Corporate Communications
+91-98104-76075
[email protected]

March 16, 2021 8:33 am

Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium

Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium

RENAsym SAB to Provide Insights and Guidance for Development of Kidney Injury Software

LANCASTER, Calif.–(BUSINESS WIRE)–
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division has formed a Scientific Advisory Board (SAB) to provide guidance and direction for development of its RENAsym quantitative systems toxicology (QST) kidney injury software platform.

The SAB has been formed within the RENAsym Consortium, and consists of the following experts:

Dr. Lauren Aleksunes, Professor of Pharmacology and Toxicology at the Rutgers University Ernest Mario School of Pharmacy;
Dr. Zheng Dong, Regents’ Professor and Leon H. Charbonnier Endowed Chair at the Medical College of Georgia of Augusta University and the Director of Research & Development at the Charlie Norwood VA Medical Center;
Dr. K. Melissa Hallow, Associate Professor at the University of Georgia School of Chemical, Materials, and Biomedical Engineering;
Dr. Ravindra Mehta, Professor at the University of California at San Diego School of Medicine;
Dr. Frank D. Sistare, Former Scientific Associate Vice President at Merck Research Laboratories and Captain in the U.S. Public Health Service at the Food and Drug Administration’s Center for Drug Evaluation and Research;
Dr. Paul B. Watkins, RENAsym and DILI-sim SAB Chair, Howard Q. Ferguson Distinguished Professor and Director of the Institute for Drug Safety Sciences at the University of North Carolina.

For the past 10 years, DSS has coordinated the DILI-sim Initiative, which is a public-private partnership that has guided development of the DILIsym^® software package. The RENAsym Consortium was recently launched in a similar fashion for the development of the RENAsym^® software program, which uses properties of drugs to predict their risk of causing kidney injury in patients. RENAsym version 1A will be released in the latter half of 2021 for drug developers to use in-house or engage via consulting. The combined liver and kidney safety capabilities of DILIsym and RENAsym will allow DSS to address a larger portion of the safety issues facing drug developers.

Dr. Paul B. Watkins, chair of the Scientific Advisory Board of the RENAsym Consortium, remarked: “Given the tremendous success of the DILIsym^® software in predicting liver injury due to drugs, many stakeholders urged the team to take on kidney toxicity and we are delighted to see this happening. The members of the Scientific Advisory Board are internationally recognized scientists with expertise spanning basic kidney biology, novel new tests to detect kidney injury, and the various ways drugs can harm kidneys in patients. I am very excited to be working with this team.”

Newly appointed SAB member, Dr. Frank Sistare, commented: “I am honored to be part of this effort. Drug safety toolboxes are expanding in areas of region-specific translational kidney safety biomarkers, advanced in vitro kidney models, and mechanistic molecular tissue biomarkers. It makes perfect sense to work collaboratively to expand mathematical modeling capabilities that can pull these data streams together to provide more accurate perspectives on kidney effects at target clinical exposures and improve drug development decision making.”

Dr. Brett A. Howell, president of DILIsym Services, added, “All of our new RENAsym SAB members are extremely knowledgeable and distinguished scientific leaders. Our establishment of this new SAB under the RENAsym Consortium umbrella is just another example of our commitment to top level science within our products and services.”

About Simulations Plus, Inc.

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With our subsidiaries, Cognigen, DILIsym Services, and Lixoft, we offer solutions which bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, consumer goods companies and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | Read our Environmental, Social, and Governance (ESG) Report.

The DILIsym Services division of Simulations Plus has developed DILIsym^® and NAFLDsym^® QSP software, and is developing IPFsym™ and RENAsym™ QSP software, to provide the pharmaceutical industry with the tools and resources to efficiently develop safe and effective drug therapies. DILIsym and RENAsym are designed to address drug-induced liver injury (DILI) and drug-induced acute kidney injury, respectively. NAFLDsym and IPFsym are designed for target or compound evaluation of therapeutic efficacy in nonalcoholic fatty liver disease (NAFLD or NASH) and idiopathic pulmonary fibrosis (IPF), respectively. More information is available on the company’s web page.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 – With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Words like “believe,” “expect,” and “anticipate” mean that these are our best estimates as of this writing, but that there can be no assurances that expected or anticipated results or events will actually take place, so our actual future results could differ significantly from those statements. Factors that could cause or contribute to such differences include, but are not limited to: our ability to maintain our competitive advantages, acceptance of new software and improved versions of our existing software by our customers, the general economics of the pharmaceutical industry, our ability to finance growth, our ability to continue to attract and retain highly qualified technical staff, our ability to identify and close acquisitions on terms favorable to the Company, and a sustainable market. Further information on our risk factors is contained in our quarterly and annual reports and filed with the U.S. Securities and Exchange Commission.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005399/en/

Simulations Plus Investor Relations

Ms. Renee Bouche

661-723-7723

[email protected]

Hayden IR

Mr. Cameron Donahue

651-653-1854

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Science Software Other Science Biotechnology Research Pharmaceutical Health Technology

MEDIA:

Logo

March 16, 2021 8:33 am

Safe-T & ImageWare Systems Introduce the First-Ever Biometric-Based Zero Trust Network Access Solution

HERZLIYA, Israel, March 16, 2021 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions and intelligent data collection, today announced the availability of a joint Zero Trust Network Access (ZTNA) solution in collaboration between its wholly owned subsidiary, Safe-T Data A.R Ltd., and ImageWare Systems, Inc. (OTCQB: IWSY), a provider of defense-grade biometric identification and authentication for access to data, products, services or facilities. The joint solution delivers the first ever biometric-based ZTNA solution.

The way business gets done has forever changed since the beginning of the COVID-19 pandemic. In years prior, most employees worked in an office environment with remote staff being the exception instead of the rule. Employees connecting to the corporate network in the office were under control of the organization, fully trusted and broadly granted access with just a username and password.

Today, offices are distributed and remote, with access to an organization’s data resources required from not only employees, but contractors, partners, and customers. This new office paradigm creates the need for different levels of trust across different users and connection types. Add in that software and services are now a mix of on-premises and cloud systems with the majority of access requests coming from remote, sometimes unknown, untrusted devices, and the complexity and risks of access control management are at unprecedented levels.

“To adequately safeguard corporate infrastructure in today’s dispersed work environment, companies require increased span across services, precise user identification, and a risk assessment of the connecting devices,” said Eitan Bremler, Co-Founder and VP Corporate Development at Safe-T. “This is something way beyond the scope of current remote access and authentication solutions like VPNs and passwords provide.”

The joint solution between Safe-T’s ZoneZero™ and ImageWare Authenticate addresses all access challenges with a simple and secure ZTNA solution. Before granting access, the solution collects and matches biometrics, either in cloud or on-premises, to ensure the user’s true identity. Once biometrically authenticated, the solution grants access on a need-to-know basis only while still providing users (managed and un-managed) fast and seamless access to the resources they need.

“With the new demands brought on by remote work, it has become clear that virtual private networks and passwords are no longer effective in securing access to data and services,” said Kristin Taylor, CEO and Chair at ImageWare. “The addition of biometric authentication to Zero Trust provides an additional layer of security through precise identification while also improving the user experience with quick, contactless authentication. Our joint solution brings best-of-breed in Zero Trust and biometrics for unparalleled access management security for today’s remote world.”

ImageWare Authenticate delivers precise user assurance through a rich suite of on-device and cloud-based biometrics such as a face or palm print, for fast, convenient access control with a level of security only biometric authentication can provide.

Safe-T’s ZoneZero™ changes the way organizations grant secure access to their services. ZoneZero™ acts as a Perimeter Access Orchestration, or PAO, platform, providing central management of all secure access technologies and use cases for ZTNA.

Together, ImageWare Authenticate and Safe-T ZoneZero™ have established an unrivalled ZTNA solution, controlling who can have access to all corporate resources and how this access is granted. The result is a true user-assurance-first, secured-access-second approach: ImageWare Authenticate for biometric authentication and Safe-T ZoneZero™ for access to corporate services.

About Safe-T®

Safe-T Group Ltd. (Nasdaq, TASE: SFET) is a provider of access solutions and intelligent data collection.

Our cloud and on-premises solutions mitigate attacks on enterprises’ business-critical services and sensitive data, while ensuring uninterrupted business continuity. Organization’s access use cases, whether into the organization or from the organization out to the internet, are secured according to the “validate first, access later” philosophy of Safe-T’s zero trust. This means that no one is trusted by default from inside or outside the network, and verification is required from everyone trying to gain access to resources on the network or in the cloud.

The wide range of access solutions, empowered by our patented reverse-access technology and proprietary routing technology, reduce organizations’ attack surface, improve their ability to defend against modern cyberthreats and enable them smooth digital transformation and to safely migrate to the cloud.

We also offer intelligent data collection cloud service, based on our world’s fastest and most advanced & secured business proxy network which enables clients to collect accurate, transparent & sensitive data from public online sources.

Safe-T’s SDP solution on AWS Marketplace is available here
For more information about Safe-T, visit www.safe-t.com

About ImageWare® Systems, Inc.

Founded in 1987, ImageWare provides defense-grade biometric identification and authentication for access to your data, products, services or facilities. We are experts in biometric authentication and considered a preeminent patent holder of multimodal IP, having many of the most-cited patents in the industry. Our patented IWS Biometric Engine® (BE) is the most accurate and fastest biometrics matching engine in the industry, capable of our patented fusion of multiple biometrics. Part of our heritage is in law enforcement, having built the first state-wide digital booking platform for United States local law enforcement – and more than three decades of experience in the challenging government sector creating biometric smart cards and logical access for millions of individuals. We are a “biometrics first” company, leveraging unique human characteristics to provide unparalleled accuracy for identification while protecting your identity. For more information, please visit www.iwsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Safe-T is using forward-looking statements in this press release when it discusses the advantages and capabilities of its ZoneZero™ solution, the advantages, capabilities and superiority of the joint solution with ImageWare Systems Inc. and the potential of this solution to address end-users and market requirements. Because such statements deal with future events and are based on Safe-T’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Safe-T could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Safe-T’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Safe-T undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Safe-T is not responsible for the contents of third-party websites.

INVESTOR RELATIONS CONTACT

Chris Tyson
Executive Vice President
MZ Group – MZ North America
949-491-8235
[email protected]
www.mzgroup.us

Michal Efraty
+972-(0)52-3044404
[email protected]

March 16, 2021 8:33 am

Ross Stores Announces Changes To Its Board Of Directors

Ross Stores Announces Changes To Its Board Of Directors

DUBLIN, Calif.–(BUSINESS WIRE)–
Ross Stores, Inc. (NASDAQ: ROST) announced today the following changes to the composition and leadership of its Board of Directors:

The Board expects to name George Orban as Chairman of the Board and Barbara Rentler, Chief Executive Officer, as Vice Chair. These Board leadership changes will become effective following the Company’s Annual Stockholders Meeting on May 19, 2021.
Michael Hartshorn, Group President and Chief Operating Officer, has been elected to the Board effective March 10, 2021.
Our current Chairman Michael Balmuth, and Chairman Emeritus Norman Ferber, will not be standing for re-election as directors at the upcoming Annual Meeting. Both Mr. Balmuth and Mr. Ferber will have ongoing, active roles as senior advisors to the Company.

In commenting on this news, Michael Balmuth, Chairman of Ross Stores, said, “Norman Ferber and our entire Board of Directors join me in congratulating George Orban and Barbara Rentler on their pending new Board leadership roles. We believe that their combined decades of in-depth business knowledge and experience at Ross are invaluable resources that will benefit our stockholders as they lead the Board and the Company.”

Mr. Balmuth continued, “We are also pleased to welcome Michael Hartshorn to our Board. Michael is a very talented executive with over 30 years of proven retail leadership experience, including more than two decades at Ross. He brings valuable strategic insights as well as his broadbased knowledge and operational and financial expertise.”

Mr. Balmuth concluded, “While Norman Ferber and I will no longer be serving as Board members after our current terms end in May, we remain passionate about Ross and enthusiastic about its future business opportunities. We look forward to staying actively involved in providing our counsel to the Board and the senior management team in our ongoing senior advisor positions.”

Ross Stores, Inc. is an S&P 500, Fortune 500, and Nasdaq 100 (ROST) company headquartered in Dublin, California, with fiscal 2020 revenues of $12.5 billion. Currently, the Company operates Ross Dress for Less^® (“Ross”), the largest off-price apparel and home fashion chain in the United States with 1,589 locations in 40 states, the District of Columbia, and Guam. Ross offers first-quality, in-season, name brand and designer apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 60% off department and specialty store regular prices every day. The Company also operates 277 dd’s DISCOUNTS^® in 21 states that feature a more moderately-priced assortment of first-quality, in-season, name brand apparel, accessories, footwear, and home fashions for the entire family at savings of 20% to 70% off moderate department and discount store regular prices every day. Additional information is available at www.rossstores.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005299/en/

Travis Marquette

Executive Vice President, Chief Financial Officer

(925) 965-4550

Connie Kao

Group Vice President, Investor Relations

(925) 965-4668

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Retail Discount/Variety Department Stores Fashion

MEDIA:

Logo

March 16, 2021 8:33 am

Sigyn Therapeutics Announces Force Wealth Roundtable Forum with Goldman Small Cap Research

The Event Occurs Tomorrow, March 17th at 12pm Eastern / 9am Pacific Time

SAN DIEGO, March 16, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), a medical technology company focused on the treatment of life-threatening inflammatory conditions precipitated by Cytokine Storm Syndrome, announced today that its Chairman and CEO, Jim Joyce, will participate in a “live” roundtable forum with Rob Goldman of Goldman Small Cap Research to discuss the science and clinical opportunities that underlie Sigyn Therapy™, a novel blood purification technology designed to treat sepsis and other life-threatening conditions that stem from cytokine storm syndrome.

This exclusive Force Family Office event occurs tomorrow, March 17, 2021 at 12:00pm Eastern Time / 9:00 am Pacific Time. Click on the following link to register for the event: https://forcewealth.com/portfolio-items/sigyn-03-17/?portfolioCats=28

About Sigyn Therapeutics

Sigyn Therapeutics™ is a development-stage therapeutic technology company headquartered in San Diego, California USA. Our focus is directed toward a significant unmet need in global health; the treatment of life-threatening inflammatory conditions that are precipitated by Cytokine Storm Syndrome and not addressed with an approved therapy. Our mission is to save lives.

Sigyn Therapy™ is a novel blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Cytokine storm syndrome is the hallmark of sepsis, which is the most common cause of in-hospital deaths and claims more lives each year than all forms of cancer combined. Virus induced cytokine storm (VICS) is associated with high mortality and is a leading cause of SARS-CoV-2 (COVID-19) deaths. Other therapeutic opportunities include, but are not limited to bacteria induced cytokine storm (BICS), acute respiratory distress syndrome (ARDS) and acute forms of liver failure, such as hepatic encephalopathy.

To learn more, visit www.SigynTherapeutics.com

About Rob Goldman at Goldman Small Cap Research

Rob Goldman founded Goldman Small Cap Research in 2009. He leads the Firm’s investment research strategy, and oversees a team of contractor analysts and editors, while serving as chief analyst. Rob has over 25 years of investment and company research experience as a senior research analyst and as a portfolio and mutual fund manager. During his tenure as a sell-side analyst, Rob was a senior member of Piper Jaffray’s Technology and Communications teams. Prior to joining Piper, Rob led Josephthal & Co.’s Washington-based Emerging Growth Research Group. In addition to his sell-side experience Rob served as Chief Investment Officer of a boutique investment management firm and Blue and White Investment Management, where he managed Small Cap Growth portfolios and The Blue and White Fund. As an investment manager, Rob’s model portfolio was once ranked the 4th best small cap growth performer in the U.S. by Money Manager Review.

To learn more, visit www.goldmanresearch.com

About Force Family Office

FORCE works with Family Offices, Foundations, and Endowments by introducing them to leaders of public companies looking for open market buyers and privately held businesses at the capital acquisition stage. We’re constantly bringing unique opportunities and information to our community and make connections by actively seeking out best-in-class companies for introduction. In addition, our elite peer-to-peer community brings individuals, endowments and foundations together all over the world, facilitating both information sharing with symposiums, networking events, and conferences.

To learn more, visit www.forcewealth.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements of Sigyn Therapeutics, Inc. (“Sigyn”) that involve substantial risks and uncertainties. All statements contained in this press release are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words “could,” “will,” “plan,” “intend,” “anticipate,” “approximate,” “expect,” “potential,” or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These forward-looking statements include, among others, statements about Sigyn’s future financial performance, the impact of management changes, any proposed organizational restructuring, results of operations, capital resources to fund operations; statements about Sigyn’s expectations regarding the capitalization, resources and ownership structure of the combined company; statements about the potential benefits of the transaction; the expected completion and timing of the transaction and other information relating to the transaction; and any other statements other than statements of historical fact. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that Sigyn makes due to a number of important factors, including (i) the risk that the transaction may not be completed in a timely manner or at all, which may adversely affect Sigyn’s business and the price of the common stock of Sigyn, (ii) the failure to satisfy of the conditions to the consummation of the transaction, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement, (iv) risks related to the ability to realize the anticipated benefits of the transaction, including the risk that the businesses will not be integrated successfully, (v) the effect of the announcement or pendency of the transaction on Sigyn’s business relationships, operating results and business generally, (vi) risks that the proposed transaction disrupts current plans and operations, (vii) risks related to the combined entity’s ability to up-list to a national securities exchange, (viii) risks related to the combined entity’s access to existing capital and fundraising prospects to fund its ongoing operations, (ix) risks related to diverting management’s attention from Sigyn’s ongoing business operations, (x) other business effects, including the effects of industry, market, economic, political or regulatory conditions, future exchange and interest rates, and changes in tax and other laws, regulations, rates and policies, and (xi) risks related to an inability to manufacture Sigyn Therapy, risks related to the clinical advancement of Sigyn Therapy with regulatory agencies, and no assurance that Sigyn Therapy will be proven to be a safe and efficacious treatment for any condition. The forward-looking statements in this press release represent Sigyn’s views as of the date of this press release. Sigyn anticipates that subsequent events and developments may cause its views to change. However, while it may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. You should, therefore, not rely on these forward-looking statements as representing Sigyn’s views as of any date subsequent to the date of this press release.

Contact Sigyn Therapeutics, Inc.

Jim Joyce

Chairman, CEO

(619) 368-2000

[email protected]

March 16, 2021 8:33 am

Live Webcast: Deliver Better Business Outcomes – Managing Supply Variability

Live Webcast: Deliver Better Business Outcomes – Managing Supply Variability

Part Two of Live Series Uncovers Additional Supply Chain Resilience Insights

ATLANTA–(BUSINESS WIRE)–
Logility, Inc., a leader in supply chain innovation powering the sustainable and resilient enterprise, invites you to part two of the webcast series, Deliver Better Business Outcomes – Managing Supply Variability. Join industry leaders Lora Cecere, founder, Supply Chain Insights, and Mac McGary, executive vice president, Logility, as they explore how to build a more resilient supply chain to quickly respond to shifts in today’s dynamic market.

Following the unprecedented challenges of 2020, supply chain leaders must be able to sense and respond quickly to risks and opportunities in both supply and demand. This online webcast will continue the discussion and help the audience learn what it means to deliver better business outcomes in 2021 through the lens of managing supply variability. The webcast will discuss the causes of supply variability, initiatives to address the challenge, metrics to measure success, and segmentation to align these efforts across a complex, global supply chain.

Webcast at a Glance:

Title: Deliver Better Business Outcomes (Part 2) – Managing Supply Variability
Speakers: Lora Cecere, founder, Supply Chain Insights, and Mac McGary, executive vice president, Logility
When: Wednesday, March 24, 2021 at 11 a.m. EST
Register Today: https://bit.ly/38bshha

About Logility

Accelerating the digital sustainable supply chain, Logility helps companies seize new opportunities, sense and respond to changing market dynamics and more profitably manage their complex global businesses. The Logility® Digital Supply Chain Platform leverages an innovative blend of artificial intelligence (AI) and advanced analytics to automate planning, accelerate cycle times, increase precision, improve operating performance, break down business silos and deliver greater visibility. Logility’s SaaS-based platform transforms sales and operations planning (S&OP) and integrated business planning (IBP) processes; demand, inventory and replenishment planning; global sourcing; quality and compliance management; product life cycle management; supply and inventory optimization; manufacturing planning and scheduling; retail merchandise planning, assortment and allocation. Logility customers include Big Lots, Husqvarna Group, Parker Hannifin, Sonoco Products and Red Wing Shoe Company. Logility is a wholly owned subsidiary of American Software, Inc. (NASDAQ: AMSWA). To learn how Logility can help you make smarter decisions faster, visit www.logility.com.

Forward-Looking Statements

This press release contains forward-looking statements that are subject to substantial risks and uncertainties. There are a number of factors that could cause actual results or performance to differ materially from what is anticipated by statements made herein. These factors include, but are not limited to, continuing U.S. and global economic uncertainty and the timing and degree of business recovery; the irregular pattern of the Company’s revenues; dependence on particular market segments or customers; competitive pressures; market acceptance of the Company’s products and services; technological complexity; undetected software errors; potential product liability or warranty claims; risks associated with new product development; the challenges and risks associated with integration of acquired product lines, companies and services; uncertainty about the viability and effectiveness of strategic alliances; American Software, Inc.’s ability to satisfy in a timely manner all Securities and Exchange Commission (SEC) required filings and the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and the rules and regulations adopted under that Section; as well as a number of other risk factors that could affect the Company’s future performance. For further information about risks the Company and American Software could experience as well as other information, please refer to American Software, Inc.’s current Form 10-K and other reports and documents subsequently filed with the SEC. For more information, contact: Kevin Liu, American Software, Inc., (626) 657-0013 or email [email protected].

Logility® is a registered trademark of Logility, Inc. Other products mentioned in this document are registered, trademarked or service marked by their respective owners.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005188/en/

Justin Siefert

Logility

[email protected]

(404) 264-5485

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Other Manufacturing Technology Packaging Transport Manufacturing Software Logistics/Supply Chain Management Retail Supply Chain Management

MEDIA:

Logo